Business profile not generated.
Run python -m application.cli.business_profile run --market US --one BRNS, then regenerate the site.
Issue 000 | U.S. Pilot | US
BRNS
Barinthus Biotherapeutics plc.
Passing
Verified
10-Q | 2026-04-30
Filing currency: USD
Margin of Safety
46.1%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 72,664,000USD
- Total Liabilities
- 25,665,000USD
- NCAV
- 46,999,000USD
- Cash
- 65,858,000USD
- NCAV per share
- 1.15USD/share
- Evidence
- 5 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
|---|---|---|---|---|---|
| Revenue | 0 | 14,969,000 | 802,000 | 44,703,000 | 268,000 |
| Operating Income | -70,555,000 | -67,970,000 | -83,914,000 | -4,041,000 | -45,221,000 |
| Net Income | -66,428,000 | -61,074,000 | -73,347,000 | 5,342,000 | -50,865,000 |
| Cash From Operations | -47,979,000 | -28,940,000 | -50,925,000 | -14,431,000 | -32,583,000 |
| Capex | -37,000 | -892,000 | -5,413,000 | -6,138,000 | -1,146,000 |
| Free Cash Flow | -48,016,000 | -29,832,000 | -56,338,000 | -20,569,000 | -33,729,000 |
| Cash And Equivalents | 70,456,000 | 110,662,000 | 142,090,000 | 194,385,000 | 214,054,000 |
| Accounts Receivable | n/a | n/a | n/a | 323,000 | 20,000 |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 77,790,000 | 125,742,000 | 156,905,000 | 213,041,000 | 226,765,000 |
| Total Assets | 98,169,000 | 160,327,000 | 214,506,000 | 270,205,000 | 280,715,000 |
| Total Current Liabilities | 10,018,000 | 15,657,000 | 12,598,000 | 12,242,000 | 11,158,000 |
| Total Liabilities | 23,877,000 | 30,192,000 | 27,511,000 | 27,004,000 | 28,153,000 |
| Shareholders Equity | 74,208,000 | 130,029,000 | 186,784,000 | 242,896,000 | 252,562,000 |
| Shares Outstanding | 40,848,893 | 40,234,663 | 38,643,540 | 37,683,531 | 37,188,730 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 40,527,218 | 39,348,240 | 38,386,491 | 38,169,307 | 25,894,375 |
| Weighted Avg Shares Basic | 40,527,218 | 39,348,240 | 38,386,491 | 37,248,126 | 25,894,375 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | 0 | 14,969,000 | 0 | 0 | 0 | 0 | 334,000 | 468,000 | 6,457,000 | 6,165,000 | 17,063,000 | 15,018,000 | -1,000 | 19,000 | 35,000 |
| Operating Income | -6,075,000 | -11,565,000 | -15,066,000 | -23,324,000 | -20,600,000 | -23,390,000 | -9,380,000 | -18,286,000 | -16,914,000 | -19,988,000 | -16,105,000 | -26,337,000 | -21,484,000 | -26,036,000 | 7,553,000 | 13,788,000 | 654,000 | -16,668,000 | -5,536,000 | -16,845,000 |
| Net Income | -5,531,000 | -11,090,000 | -14,566,000 | -21,124,000 | -19,648,000 | -20,540,000 | -8,114,000 | -16,931,000 | -15,489,000 | -17,293,000 | -14,072,000 | -23,802,000 | -18,180,000 | -21,189,000 | 8,242,000 | 15,693,000 | 2,596,000 | -15,113,000 | -4,557,000 | -15,927,000 |
| Cash From Operations | -3,366,000 | -4,242,000 | -10,726,000 | -18,109,000 | -14,902,000 | 13,086,000 | -18,198,000 | -12,006,000 | -11,822,000 | -19,603,000 | -11,191,000 | -16,957,000 | -3,174,000 | -11,343,000 | 11,884,000 | -8,393,000 | -6,579,000 | -7,972,000 | -2,018,000 | -14,624,000 |
| Capex | 0 | 0 | 0 | -32,000 | -5,000 | -278,000 | -114,000 | -192,000 | -308,000 | 153,000 | -36,000 | -3,023,000 | -2,507,000 | -586,000 | -2,406,000 | -2,054,000 | -1,092,000 | -424,000 | -128,000 | -202,000 |
| Free Cash Flow | -3,366,000 | -4,242,000 | -10,726,000 | -18,141,000 | -14,907,000 | 12,808,000 | -18,312,000 | -12,198,000 | -12,130,000 | -19,450,000 | -11,227,000 | -19,980,000 | -5,681,000 | -11,929,000 | 9,478,000 | -10,447,000 | -7,671,000 | -8,396,000 | -2,146,000 | -14,826,000 |
| Cash And Equivalents | 65,858,000 | 70,456,000 | 74,272,000 | 86,259,000 | 99,118,000 | 110,662,000 | n/a | n/a | n/a | 142,090,000 | 160,309,000 | 173,030,000 | 191,328,000 | 194,385,000 | 200,104,000 | 192,327,000 | 200,596,000 | 214,054,000 | 233,871,000 | 243,619,000 |
| Total Current Assets | 72,664,000 | 77,790,000 | 86,781,000 | 100,414,000 | 109,882,000 | 125,742,000 | 134,654,000 | 131,879,000 | 143,131,000 | 156,905,000 | 171,065,000 | 184,777,000 | 200,665,000 | 213,041,000 | 218,621,000 | 226,291,000 | 230,783,000 | 226,765,000 | 245,979,000 | 256,728,000 |
| Total Liabilities | 25,665,000 | 23,877,000 | 24,640,000 | 27,080,000 | 26,403,000 | 30,192,000 | 29,228,000 | 29,959,000 | 27,466,000 | 27,511,000 | 34,367,000 | 28,666,000 | 28,247,000 | 27,004,000 | 31,329,000 | 30,289,000 | 32,986,000 | 28,153,000 | 14,100,000 | 9,927,000 |
| Shares Outstanding | 40,848,893 | 40,848,893 | 40,827,263 | 40,348,665 | 40,339,395 | 40,234,663 | 39,542,518 | 39,184,338 | 38,952,956 | 38,643,540 | 38,546,594 | 38,524,059 | 38,357,025 | 37,683,531 | 37,291,492 | 37,216,162 | 37,193,367 | 37,188,730 | 34,328,231 | 34,328,231 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 40,848,893 | 40,527,218 | 40,661,118 | 40,343,521 | 40,265,216 | 39,348,240 | 39,419,447 | 39,041,111 | 38,773,482 | 38,386,491 | 38,533,833 | 38,407,672 | 38,013,399 | 38,169,307 | 38,226,092 | 38,260,579 | 38,346,668 | 25,894,375 | 34,843,154 | 24,897,665 |
| Weighted Avg Shares Basic | 40,848,893 | 40,527,218 | 40,661,118 | 40,343,521 | 40,265,216 | 39,348,240 | 39,419,447 | 39,041,111 | 38,773,482 | 38,386,491 | 38,533,833 | 38,407,672 | 38,013,399 | 37,248,126 | 37,247,123 | 37,202,600 | 37,191,022 | 25,894,375 | 34,843,154 | 24,897,665 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 72,664,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001828185/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json |
| Total Liabilities | 25,665,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001828185/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json |
| Cash | 65,858,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001828185/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json |
| Shares Outstanding | 40,848,893 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001828185/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json |
| NCAV | 46,999,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 1.15USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 46.1% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001828185
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001828185\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 21
- Imported At
- 2026-07-04T23:04:26+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001828185-26-000019
- CIK
- 0001828185
- Mary Filing Date
- 2026-04-30
- Filing Currency
- USD
- Internal Discount
- 46.1%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-04-30; mary_accession=0001828185-26-000019; mary_cik=0001828185; gnni_supporting_filing_date=2026-04-30; internal_discount=0.461131; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.